ReviewAmerican journal of ophthalmology2022

Challenges of Cost-Effectiveness Analyses of Novel Therapeutics for Inherited Retinal Diseases.

K Thiran Jayasundera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.